We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Whitepaper

Investigating Cell-Free DNA in Liquid Biopsy

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.
Whitepaper

Lyophilization: The Future of Molecular Diagnostics

The need for molecular diagnostic assays is growing at an unprecedented rate and the discovery of new biomarkers and improved accessibility to standard catalog reagents has allowed the creation of molecular tests faster than ever before.
Whitepaper

Real-Time PCR Biopharma Resources

Real-time PCR, also known as quantitative PCR (qPCR), is the gold-standard for sensitive, specific detection and quantification of nucleic acid targets and qPCR methods have become core technologies for delivering high-quality results in a range of applications throughout biologics development and biomanufacturing.
Whitepaper

Reagent Manufacturing for a Novel CRISPR-Based Diagnostic SARS CoV-2 Test

Download this whitepaper to discover how the manufacturing process was successfully scaled using operational support, a customized solution as well as a highly collaborative and strategic engagement.
Whitepaper

Lateral Flow Assay Development Using Dyes Across the Spectrum

Download this whitepaper to discover assay development tools that can help you to image various dyes with different excitation and emission wavelengths, achieve a high degree of photostability as well as detect the presence of proteins including SARS-CoV-2's spike protein.
Whitepaper

Non-Invasive Monitoring of Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD), a liver condition that is characterized by liver steatosis accompanied by liver cell injury and inflammation.
Whitepaper

Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes

Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.
Whitepaper

Can Your Clinical Diagnostics Contract Manufacturer Weather Supply Chain Challenges?

Supply chain security and transparency is a key part of the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Prior to the COVID-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed towards lower cost raw material providers located in different geographies.
Whitepaper

10 Strategic Considerations When Outsourcing Production of In Vitro Diagnostics

The choice of whether to outsource production of an in vitro diagnostic (IVD) or invest and develop inhouse capabilities is a foundational business decision. Capacity, capabilities and resources must all be assessed to determine the best course of action.
Whitepaper

Best Practices for Biobanks and Biorepositories

Biobanks and biorepositories play a crucial role in medical research by offering robust, readily available and even rare biospecimen samples for clinical, biomedical and research studies.
Advertisement